← Back
Data updated: Mar 10, 2026
AGNITIO
ImmunologyRespiratoryGastroenterology
AGNITIO is a generic drug manufacturer focused on Immunology, Respiratory, Gastroenterology.
2019
Since
3
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PHYTONADIONE 2026-01-09
PHYTONADIONE 2025-11-04
PHYTONADIONE 2025-09-08
PHYTONADIONE 2025-04-17
PHYTONADIONE 2025-01-03
PHYTONADIONE 2024-12-19
PHYTONADIONE 2024-12-10
PHYTONADIONE 2024-07-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 25%
1 drugs
Respiratory 25%
1 drugs
Gastroenterology 25%
1 drugs
Cardiovascular 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Novartis big-pharma
Cardiovascular, Immunology, Respiratory
LEGACY PHARMA big-pharma
Respiratory, Gastroenterology, Immunology, Cardiovascular
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
AstraZeneca big-pharma
Respiratory, Cardiovascular, Immunology
COREPHARMA other
Cardiovascular, Respiratory, Immunology, Gastroenterology
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2019-07-12
- Latest
- 2023-10-12
- Applications
- 3